Annandale Capital, LLC

Position in DHR — Danaher Corp /De/

CIK 1811739 DALLAS, TX

Position in DHR

as of Jun 30, 2026 · filed Aug 13, 2026 Compact

Position Value

$1,490,886

+$6,887 QoQ

Shares Held

7,827

0.0% QoQ

Ownership

0.001%

of shares outstanding

% of Portfolio

0.45%

of 13F equity value

Holder Rank

#970

of 2,098 holders

Holding Since

Jun 2023

8 quarters on record

Voting authority Sole 0% Shared 0% None 100%

Healthcare · as of Jun 30, 2026

Annandale Capital, LLC holds $6,095,710 across 4 Diagnostics & Research names. DHR ranks #2 (24.5% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	TMO	Thermo Fisher Scientific Inc.	5,452	$2,733,414
2	DHR	Danaher Corp /De/ This page	7,827	$1,490,886
3	IQV	Iqvia Holdings Inc.	5,300	$1,024,066
4	MEDP	Medpace Holdings, Inc.	1,600	$847,344

8 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$1,490,886	7,827	0.0%	Shares	Sole	2026-08-13
2026-03-31	$1,483,999	7,827	+0.2%	Shares	Sole	2026-05-15
2025-12-31	$1,789,009	7,815	0.0%	Shares	Sole	2026-02-12
2025-09-30	$15,494	7,815	+53.2%	Shares	Sole	2025-11-13
2025-06-30	$1,007,454	5,100	+96.2%	Shares	Sole	2025-08-13
2023-12-31	$601,484	2,600	-3.7%	Shares	Sole	2024-02-14
2023-09-30	$669,869	2,700	0.0%	Shares	Sole	2023-11-15
2023-06-30	$648,000	2,700	—	Shares	Sole	2023-08-14
No filing history on record for this holder in this stock.